Black Diamond Therapeutics Inc. (BDTX) NASDAQ

$1.67 0.13 (8.44%)

Market Cap: $60.61M

As of 05/27/22 04:00 PM EDT. Market closed.

(BDTX)

Black Diamond Therapeutics Inc. (BDTX) NASDAQ

$1.67 0.13 (8.44%)

Market Cap: $60.61M

As of 05/27/22 04:00 PM EDT. Market closed.

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Black Diamond is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. The Company's proprietary technology platform, ... read more

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. Black Diamond targets undrugged mutations in patients with genetically defined cancers. Black Diamond is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry. The Company's proprietary technology platform, Mutation-Allostery-Pharmacology, or MAP, platform, is designed to allow Black Diamond to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families, and develop a single small molecule therapy in a tumor-agnostic manner that targets a specific family of mutations. Black Diamond was founded by David M. Epstein, Ph.D., and Elizabeth Buck, Ph.D., and, beginning in 2017, together with Versant Ventures, began building the MAP platform and chemistry discovery engine. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
73
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$1.55
Previous Close
$1.54
Days Range
$1.48 - $1.68
52 week range
$1.46 - $13.57
Volume
159,234
Avg. Volume (30 days)
225,723
Market Cap
$60.61M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
36,290,901
Open
$1.55
Previous Close
$1.54
Days Range
$1.48 - $1.68
52 week range
$1.46 - $13.57
Volume
159,234
Avg. Volume (30 days)
225,723
Market Cap
$60.61M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
36,290,901

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BLACK DIAMOND THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
BIOTECH GROWTH N V 10% Owner Apr 28, 2022 Buy $2.57 255,711 657,868 4,694,113 Apr 29, 2022, 10:50 AM
BIOTECH GROWTH N V 10% Owner Apr 27, 2022 Buy $2.66 150,000 399,480 4,438,402 Apr 29, 2022, 10:50 AM
BIOTECH GROWTH N V 10% Owner Apr 19, 2022 Buy $3.24 150,000 486,645 4,288,402 Apr 20, 2022, 12:56 PM
BIOTECH GROWTH N V 10% Owner Apr 18, 2022 Buy $3.29 150,000 493,935 4,138,402 Apr 20, 2022, 12:56 PM
BIOTECH GROWTH N V 10% Owner Apr 12, 2022 Buy $3.42 150,000 513,600 3,885,846 Apr 14, 2022, 12:09 PM
BIOTECH GROWTH N V 10% Owner Apr 13, 2022 Buy $3.57 102,556 366,217 3,988,402 Apr 14, 2022, 12:09 PM
Behbahani Ali Director Mar 18, 2022 Option Exercise $3.02 4,346 13,125 9,705 Mar 18, 2022, 04:15 PM
INGRAM ROBERT ALEXANDER Director Mar 18, 2022 Option Exercise $3.02 5,795 17,501 18,397 Mar 18, 2022, 04:05 PM
Velleca Mark A. Director Mar 18, 2022 Option Exercise $3.02 2,897 8,749 2,897 Mar 18, 2022, 04:05 PM
Behbahani Ali Director Dec 17, 2021 Option Exercise $5.31 2,472 13,126 5,359 Dec 17, 2021, 04:50 PM
INGRAM ROBERT ALEXANDER Director Dec 17, 2021 Option Exercise $5.31 3,296 17,502 12,602 Dec 17, 2021, 04:12 PM
Behbahani Ali Director Sep 17, 2021 Option Exercise $9.90 1,326 13,127 2,887 Sep 23, 2021, 05:43 PM
INGRAM ROBERT ALEXANDER Director Sep 17, 2021 Option Exercise $9.90 1,869 18,503 9,306 Sep 23, 2021, 05:33 PM
INGRAM ROBERT ALEXANDER Director Jun 18, 2021 Option Exercise $12.95 1,255 16,252 7,437 Jun 22, 2021, 06:13 PM
Hatzis-Schoch Brent See Remarks May 12, 2021 Option Exercise $3.20 4,078 13,050 12,478 May 13, 2021, 04:53 PM
Hatzis-Schoch Brent See Remarks May 12, 2021 Sale $27.42 4,078 111,805 11,317 May 13, 2021, 04:53 PM
Roberts Christopher D. Chief Scientific Officer May 03, 2021 Option Exercise $10.86 2,500 27,150 5,700 May 05, 2021, 04:31 PM
Roberts Christopher D. Chief Scientific Officer May 03, 2021 Sale $26.64 2,500 66,602 3,200 May 05, 2021, 04:31 PM
Hatzis-Schoch Brent See Remarks Apr 12, 2021 Option Exercise $3.20 4,078 13,050 12,478 Apr 13, 2021, 08:45 PM
Hatzis-Schoch Brent See Remarks Apr 12, 2021 Sale $25.00 4,078 101,950 8,400 Apr 13, 2021, 08:45 PM
Shah Rajeev M. Director Apr 01, 2021 Option Exercise $24.26 353,814 8,583,528 2,277,978 Apr 05, 2021, 04:34 PM
Behbahani Ali Director Mar 18, 2021 Option Exercise $24.01 547 13,133 547 Mar 22, 2021, 08:33 PM
Shah Rajeev M. Director Mar 18, 2021 Option Exercise $24.01 443 10,636 443 Mar 22, 2021, 08:25 PM
INGRAM ROBERT ALEXANDER Director Mar 18, 2021 Option Exercise $24.01 677 16,255 6,182 Mar 22, 2021, 08:19 PM
Hatzis-Schoch Brent See Remarks Mar 12, 2021 Option Exercise $3.20 4,078 13,050 12,478 Mar 16, 2021, 04:56 PM
Hatzis-Schoch Brent See Remarks Mar 12, 2021 Sale $26.36 4,078 107,493 8,400 Mar 16, 2021, 04:56 PM
Roberts Christopher D. Chief Scientific Officer Mar 03, 2021 Option Exercise $10.86 2,500 27,150 5,700 Mar 04, 2021, 05:52 PM
Roberts Christopher D. Chief Scientific Officer Mar 03, 2021 Sale $26.10 2,500 65,262 4,084 Mar 04, 2021, 05:52 PM
Hatzis-Schoch Brent See Remarks Feb 12, 2021 Option Exercise $3.20 4,078 13,050 12,478 Feb 12, 2021, 09:24 PM
Hatzis-Schoch Brent See Remarks Feb 12, 2021 Sale $27.23 4,078 111,025 8,707 Feb 12, 2021, 09:24 PM
Roberts Christopher D. Chief Scientific Officer Feb 03, 2021 Option Exercise $10.86 2,500 27,150 5,700 Feb 04, 2021, 05:47 PM
Roberts Christopher D. Chief Scientific Officer Feb 03, 2021 Sale $25.35 2,500 63,375 3,200 Feb 04, 2021, 05:47 PM
Hatzis-Schoch Brent See Remarks Jan 12, 2021 Option Exercise $8.16 11,578 94,500 19,978 Jan 14, 2021, 08:57 PM
Hatzis-Schoch Brent See Remarks Jan 12, 2021 Sale $34.03 11,578 394,041 17,930 Jan 14, 2021, 08:57 PM
Leggett Thomas Chief Financial Officer Jan 08, 2021 Option Exercise $10.86 3,000 32,580 3,000 Jan 11, 2021, 05:59 PM
Leggett Thomas Chief Financial Officer Jan 08, 2021 Sale $33.94 3,000 101,820 0 Jan 11, 2021, 05:59 PM
Roberts Christopher D. Chief Scientific Officer Jan 04, 2021 Option Exercise $10.86 2,500 27,150 5,700 Jan 06, 2021, 06:27 PM
Roberts Christopher D. Chief Scientific Officer Jan 04, 2021 Sale $31.41 2,500 78,525 3,737 Jan 06, 2021, 06:27 PM
Epstein David M. See Remarks Jan 04, 2021 Option Exercise $6.42 3,000 19,260 708,423 Jan 06, 2021, 06:21 PM
Epstein David M. See Remarks Jan 04, 2021 Sale $31.13 12,000 373,505 698,438 Jan 06, 2021, 06:21 PM
Hatzis-Schoch Brent See Remarks Dec 28, 2020 Option Exercise $3.20 5,400 17,280 8,400 Dec 29, 2020, 04:46 PM
INGRAM ROBERT ALEXANDER Director Dec 15, 2020 Option Exercise $34.29 505 17,316 5,505 Dec 16, 2020, 07:42 PM
Roberts Christopher D. Chief Scientific Officer Dec 15, 2020 Option Exercise $10.86 3,200 34,752 3,200 Dec 16, 2020, 07:42 PM
Hatzis-Schoch Brent See Remarks Dec 14, 2020 Option Exercise $3.20 4,078 13,050 7,078 Dec 16, 2020, 07:41 PM
Hatzis-Schoch Brent See Remarks Dec 14, 2020 Sale $34.95 4,078 142,522 3,000 Dec 16, 2020, 07:41 PM
Epstein David M. See Remarks Dec 15, 2020 Option Exercise $6.42 2,500 16,050 705,423 Dec 16, 2020, 07:39 PM
Leggett Thomas Chief Financial Officer Dec 08, 2020 Option Exercise $10.86 3,000 32,580 3,000 Dec 10, 2020, 04:16 PM
Leggett Thomas Chief Financial Officer Dec 08, 2020 Sale $33.78 3,000 101,327 1,941 Dec 10, 2020, 04:16 PM
Roberts Christopher D. Chief Scientific Officer Dec 03, 2020 Option Exercise $10.86 2,500 27,150 2,500 Dec 04, 2020, 04:34 PM
Roberts Christopher D. Chief Scientific Officer Dec 03, 2020 Sale $32.42 2,500 81,055 0 Dec 04, 2020, 04:34 PM
Epstein David M. See Remarks Dec 01, 2020 Option Exercise $6.42 3,000 19,260 714,923 Dec 03, 2020, 04:17 PM
Epstein David M. See Remarks Dec 01, 2020 Sale $32.71 12,000 392,574 704,000 Dec 03, 2020, 04:17 PM
Bolzon Bradley J PhD Director Nov 30, 2020 Sale $33.15 10,393 344,513 874,299 Dec 01, 2020, 07:13 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 30, 2020 Sale $33.15 10,393 344,513 874,299 Dec 01, 2020, 07:13 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 19, 2020 Sale $33.01 114,854 3,791,330 4,818,600 Nov 23, 2020, 04:41 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 19, 2020 Sale $33.01 15,163 500,531 968,954 Nov 23, 2020, 04:41 PM
Bolzon Bradley J PhD Director Nov 19, 2020 Sale $33.01 130,017 4,291,861 4,818,600 Nov 23, 2020, 04:39 PM
Bolzon Bradley J PhD Director Nov 17, 2020 Sale $33.05 4,194 138,611 4,933,927 Nov 19, 2020, 09:19 PM
Bolzon Bradley J PhD Director Nov 18, 2020 Sale $33.09 536 17,738 4,933,454 Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 18, 2020 Sale $33.09 473 15,653 4,933,454 Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 18, 2020 Sale $33.09 63 2,085 984,117 Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 17, 2020 Sale $33.05 3,705 122,450 4,933,927 Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 17, 2020 Sale $33.05 489 16,161 984,180 Nov 19, 2020, 09:19 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 16, 2020 Sale $33.01 177 5,843 4,937,632 Nov 17, 2020, 07:33 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 16, 2020 Sale $33.01 23 759 984,669 Nov 17, 2020, 07:33 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 13, 2020 Sale $33.77 3,975 134,253 4,939,311 Nov 17, 2020, 07:33 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 13, 2020 Sale $33.77 525 17,731 984,890 Nov 17, 2020, 07:33 PM
Bolzon Bradley J PhD Director Nov 16, 2020 Sale $33.01 200 6,603 4,937,632 Nov 17, 2020, 07:28 PM
Bolzon Bradley J PhD Director Nov 13, 2020 Sale $33.77 4,500 151,984 4,939,311 Nov 17, 2020, 07:28 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 12, 2020 Sale $34.15 13,779 470,526 4,951,587 Nov 13, 2020, 07:47 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 12, 2020 Sale $34.15 1,819 62,116 986,512 Nov 13, 2020, 07:47 PM
Bolzon Bradley J PhD Director Nov 12, 2020 Sale $34.15 15,598 532,642 4,951,587 Nov 13, 2020, 07:46 PM
Roberts Christopher D. Chief Scientific Officer Nov 11, 2020 Option Exercise $10.86 5,000 54,300 5,000 Nov 13, 2020, 04:26 PM
Roberts Christopher D. Chief Scientific Officer Nov 11, 2020 Sale $34.90 5,000 174,500 0 Nov 13, 2020, 04:26 PM
Hatzis-Schoch Brent See Remarks Nov 12, 2020 Option Exercise $3.20 4,078 13,050 7,078 Nov 13, 2020, 04:25 PM
Hatzis-Schoch Brent See Remarks Nov 12, 2020 Sale $33.99 4,078 138,607 5,511 Nov 13, 2020, 04:25 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 11, 2020 Sale $34.73 1,471 51,091 988,227 Nov 12, 2020, 05:41 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 10, 2020 Sale $33.83 23,821 805,755 5,669,956 Nov 12, 2020, 05:41 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 10, 2020 Sale $33.83 3,145 106,381 990,149 Nov 12, 2020, 05:41 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 11, 2020 Sale $34.73 11,146 387,127 5,655,404 Nov 12, 2020, 05:41 PM
Bolzon Bradley J PhD Director Nov 11, 2020 Sale $34.73 12,617 438,217 5,655,404 Nov 12, 2020, 05:38 PM
Bolzon Bradley J PhD Director Nov 10, 2020 Sale $33.83 26,966 912,136 5,669,956 Nov 12, 2020, 05:38 PM
Leggett Thomas Chief Financial Officer Nov 09, 2020 Option Exercise $10.86 3,000 32,580 3,000 Nov 12, 2020, 05:00 PM
Leggett Thomas Chief Financial Officer Nov 09, 2020 Sale $32.96 3,000 98,892 0 Nov 12, 2020, 05:00 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 09, 2020 Sale $33.06 5,565 183,954 5,681,344 Nov 10, 2020, 07:24 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 09, 2020 Sale $33.06 735 24,296 991,652 Nov 10, 2020, 07:24 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 06, 2020 Sale $33.13 2,738 90,706 5,686,909 Nov 10, 2020, 07:24 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 06, 2020 Sale $33.13 362 11,993 992,387 Nov 10, 2020, 07:24 PM
Bolzon Bradley J PhD Director Nov 06, 2020 Sale $33.13 3,100 102,698 5,686,909 Nov 10, 2020, 07:24 PM
Bolzon Bradley J PhD Director Nov 09, 2020 Sale $33.06 6,300 208,250 5,681,344 Nov 10, 2020, 07:24 PM
Bolzon Bradley J PhD Director Nov 05, 2020 Sale $33.15 8,848 293,287 5,689,647 Nov 06, 2020, 04:49 PM
Bolzon Bradley J PhD Director Nov 04, 2020 Sale $33.14 2,500 82,839 5,697,463 Nov 06, 2020, 04:49 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 04, 2020 Sale $33.14 292 9,676 993,781 Nov 06, 2020, 04:44 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 05, 2020 Sale $33.15 7,816 259,079 5,689,647 Nov 06, 2020, 04:44 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 05, 2020 Sale $33.15 1,032 34,208 992,749 Nov 06, 2020, 04:44 PM
Versant Venture Capital VI, L.P. 10% Owner Nov 04, 2020 Sale $33.14 2,208 73,164 5,697,463 Nov 06, 2020, 04:44 PM
Roberts Christopher D. Chief Scientific Officer Nov 03, 2020 Option Exercise $10.86 2,500 27,150 2,500 Nov 04, 2020, 08:37 PM
Roberts Christopher D. Chief Scientific Officer Nov 03, 2020 Sale $31.95 2,500 79,873 0 Nov 04, 2020, 08:37 PM
Epstein David M. See Remarks Nov 02, 2020 Option Exercise $6.42 3,000 19,260 723,923 Nov 03, 2020, 07:56 PM
Epstein David M. See Remarks Nov 02, 2020 Sale $31.14 12,000 373,656 712,006 Nov 03, 2020, 07:56 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 27, 2020 Sale $33.03 93 3,072 994,073 Oct 28, 2020, 05:58 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 26, 2020 Sale $33.30 7,158 238,394 5,700,378 Oct 28, 2020, 05:58 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 26, 2020 Sale $33.30 945 31,473 994,166 Oct 28, 2020, 05:58 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 27, 2020 Sale $33.03 707 23,354 5,699,671 Oct 28, 2020, 05:58 PM
Bolzon Bradley J PhD Director Oct 27, 2020 Sale $33.03 800 26,426 5,699,671 Oct 28, 2020, 05:51 PM
Bolzon Bradley J PhD Director Oct 26, 2020 Sale $33.30 8,103 269,867 5,700,378 Oct 28, 2020, 05:51 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 15, 2020 Sale $33.03 327 10,802 996,621 Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 19, 2020 Sale $33.43 3,739 124,998 5,707,536 Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 19, 2020 Sale $33.43 494 16,515 995,111 Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 16, 2020 Sale $33.57 7,697 258,410 5,711,275 Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 16, 2020 Sale $33.57 1,016 34,110 995,605 Oct 20, 2020, 08:09 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 15, 2020 Sale $33.03 2,473 81,694 5,718,972 Oct 20, 2020, 08:09 PM
Bolzon Bradley J PhD Director Oct 19, 2020 Sale $33.43 4,233 141,513 5,707,536 Oct 20, 2020, 08:03 PM
Bolzon Bradley J PhD Director Oct 16, 2020 Sale $33.57 8,713 292,520 5,711,275 Oct 20, 2020, 08:03 PM
Bolzon Bradley J PhD Director Oct 15, 2020 Sale $33.03 2,800 92,496 5,718,972 Oct 20, 2020, 08:03 PM
Bolzon Bradley J PhD Director Oct 14, 2020 Sale $33.09 5,501 182,031 5,721,445 Oct 15, 2020, 07:26 PM
Bolzon Bradley J PhD Director Oct 13, 2020 Sale $33.39 11,739 391,984 5,726,304 Oct 15, 2020, 07:26 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 14, 2020 Sale $33.09 4,859 160,787 5,721,445 Oct 15, 2020, 07:22 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 14, 2020 Sale $33.09 642 21,244 996,948 Oct 15, 2020, 07:22 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 13, 2020 Sale $33.39 10,370 346,271 5,726,304 Oct 15, 2020, 07:22 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 13, 2020 Sale $33.39 1,369 45,713 997,590 Oct 15, 2020, 07:22 PM
Hatzis-Schoch Brent See Remarks Oct 12, 2020 Option Exercise $3.20 4,078 13,050 7,078 Oct 14, 2020, 04:32 PM
Hatzis-Schoch Brent See Remarks Oct 12, 2020 Sale $32.70 4,078 133,331 3,295 Oct 14, 2020, 04:32 PM
Bolzon Bradley J PhD Director Oct 12, 2020 Sale $33.11 400 13,243 5,736,674 Oct 13, 2020, 07:48 PM
Bolzon Bradley J PhD Director Oct 09, 2020 Sale $33.67 3,800 127,933 5,737,027 Oct 13, 2020, 07:48 PM
Bolzon Bradley J PhD Director Oct 08, 2020 Sale $33.47 18,425 616,748 5,748,886 Oct 13, 2020, 07:48 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 12, 2020 Sale $33.11 47 1,556 998,959 Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 09, 2020 Sale $33.67 3,357 113,018 5,737,027 Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 09, 2020 Sale $33.67 443 14,914 999,006 Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 08, 2020 Sale $33.47 16,276 544,814 5,748,886 Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 08, 2020 Sale $33.47 2,149 71,934 1,000,571 Oct 13, 2020, 07:41 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 12, 2020 Sale $33.11 353 11,687 5,736,674 Oct 13, 2020, 07:41 PM
Leggett Thomas Chief Financial Officer Oct 08, 2020 Option Exercise $10.86 3,000 32,580 3,000 Oct 09, 2020, 04:12 PM
Leggett Thomas Chief Financial Officer Oct 08, 2020 Sale $33.53 3,000 100,576 0 Oct 09, 2020, 04:12 PM
Bolzon Bradley J PhD Director Oct 07, 2020 Sale $33.56 27,836 934,079 5,756,660 Oct 08, 2020, 07:14 PM
Bolzon Bradley J PhD Director Oct 06, 2020 Sale $33.26 18,090 601,653 5,781,250 Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 06, 2020 Sale $33.26 15,980 531,477 5,781,250 Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 06, 2020 Sale $33.26 2,110 70,176 1,044,452 Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 07, 2020 Sale $33.56 24,590 825,154 5,756,660 Oct 08, 2020, 07:14 PM
Versant Venture Capital VI, L.P. 10% Owner Oct 07, 2020 Sale $33.56 3,246 108,924 1,041,206 Oct 08, 2020, 07:14 PM
Roberts Christopher D. Chief Scientific Officer Oct 05, 2020 Option Exercise $10.86 2,500 27,150 2,500 Oct 07, 2020, 04:27 PM
Roberts Christopher D. Chief Scientific Officer Oct 05, 2020 Sale $31.28 2,500 78,188 227 Oct 07, 2020, 04:27 PM
Epstein David M. See Remarks Oct 01, 2020 Option Exercise $6.42 3,000 19,260 732,923 Oct 02, 2020, 05:07 PM
Epstein David M. See Remarks Oct 01, 2020 Sale $30.33 12,000 363,962 720,923 Oct 02, 2020, 05:07 PM
INGRAM ROBERT ALEXANDER Director Sep 30, 2020 Buy $30.46 5,000 152,285 5,000 Oct 01, 2020, 04:06 PM
Hatzis-Schoch Brent See Remarks Sep 14, 2020 Option Exercise $3.20 4,078 13,050 7,078 Sep 16, 2020, 06:11 PM
Hatzis-Schoch Brent See Remarks Sep 14, 2020 Sale $31.04 4,078 126,583 4,393 Sep 16, 2020, 06:11 PM
Leggett Thomas Chief Financial Officer Sep 14, 2020 Option Exercise $10.86 3,000 32,580 3,000 Sep 16, 2020, 06:09 PM
Leggett Thomas Chief Financial Officer Sep 14, 2020 Sale $31.00 3,000 93,000 0 Sep 16, 2020, 06:09 PM
Roberts Christopher D. Chief Scientific Officer Sep 03, 2020 Option Exercise $10.86 2,500 27,150 2,500 Sep 04, 2020, 05:27 PM
Roberts Christopher D. Chief Scientific Officer Sep 03, 2020 Sale $29.59 2,500 73,987 2,358 Sep 04, 2020, 05:27 PM
Versant Venture Capital VI, L.P. 10% Owner Aug 10, 2020 Sale $33.04 725 23,953 1,126,661 Aug 12, 2020, 07:57 PM
Versant Venture Capital VI, L.P. 10% Owner Aug 11, 2020 Sale $33.08 6,692 221,380 6,797,230 Aug 12, 2020, 07:57 PM
Versant Venture Capital VI, L.P. 10% Owner Aug 11, 2020 Sale $33.08 883 29,211 1,125,778 Aug 12, 2020, 07:57 PM
Versant Venture Capital VI, L.P. 10% Owner Aug 10, 2020 Sale $33.04 5,492 181,446 6,803,922 Aug 12, 2020, 07:57 PM
Bolzon Bradley J PhD Director Aug 11, 2020 Sale $33.08 7,575 250,591 6,797,230 Aug 12, 2020, 07:46 PM
Bolzon Bradley J PhD Director Aug 10, 2020 Sale $33.04 6,217 205,398 6,803,922 Aug 12, 2020, 07:46 PM
Versant Venture Capital VI, L.P. 10% Owner Feb 03, 2020 Buy $19.00 396,082 7,525,558 6,809,414 Feb 05, 2020, 06:02 PM
Versant Venture Capital VI, L.P. 10% Owner Feb 03, 2020 Buy $19.00 498,654 9,474,426 2,209,592 Feb 05, 2020, 06:02 PM
Bolzon Bradley J PhD Director Feb 03, 2020 Buy $19.00 894,736 16,999,984 6,809,414 Feb 05, 2020, 05:59 PM
Shah Rajeev M. Director Feb 03, 2020 Buy $19.00 1,000,000 19,000,000 1,924,164 Feb 05, 2020, 05:58 PM
Hatzis-Schoch Brent See Remarks Feb 03, 2020 Buy $19.00 3,000 57,000 3,000 Feb 05, 2020, 05:55 PM
Behbahani Ali Director Feb 03, 2020 Buy $19.00 800,000 15,200,000 3,448,757 Feb 05, 2020, 05:55 PM
Flynn James E 10% Owner Feb 03, 2020 Buy $19.00 400,000 7,600,000 778,790 Feb 03, 2020, 01:25 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
BIOTECH GROWTH N V 10% Owner 04/28/2022 657,868
BIOTECH GROWTH N V 10% Owner 04/27/2022 399,480
BIOTECH GROWTH N V 10% Owner 04/19/2022 486,645
BIOTECH GROWTH N V 10% Owner 04/18/2022 493,935
BIOTECH GROWTH N V 10% Owner 04/12/2022 513,600
BIOTECH GROWTH N V 10% Owner 04/13/2022 366,217
Behbahani Ali Director 03/18/2022 13,125
INGRAM ROBERT ALEXANDER Director 03/18/2022 17,501
Velleca Mark A. Director 03/18/2022 8,749
Behbahani Ali Director 12/17/2021 13,126
INGRAM ROBERT ALEXANDER Director 12/17/2021 17,502
Behbahani Ali Director 09/17/2021 13,127
INGRAM ROBERT ALEXANDER Director 09/17/2021 18,503
INGRAM ROBERT ALEXANDER Director 06/18/2021 16,252
Hatzis-Schoch Brent See Remarks 05/12/2021 13,050
Hatzis-Schoch Brent See Remarks 05/12/2021 111,805
Roberts Christopher D. Chief Scientific Officer 05/03/2021 27,150
Roberts Christopher D. Chief Scientific Officer 05/03/2021 66,602
Hatzis-Schoch Brent See Remarks 04/12/2021 13,050
Hatzis-Schoch Brent See Remarks 04/12/2021 101,950
Shah Rajeev M. Director 04/01/2021 8,583,528
Behbahani Ali Director 03/18/2021 13,133
Shah Rajeev M. Director 03/18/2021 10,636
INGRAM ROBERT ALEXANDER Director 03/18/2021 16,255
Hatzis-Schoch Brent See Remarks 03/12/2021 13,050
Hatzis-Schoch Brent See Remarks 03/12/2021 107,493
Roberts Christopher D. Chief Scientific Officer 03/03/2021 27,150
Roberts Christopher D. Chief Scientific Officer 03/03/2021 65,262
Hatzis-Schoch Brent See Remarks 02/12/2021 13,050
Hatzis-Schoch Brent See Remarks 02/12/2021 111,025
Roberts Christopher D. Chief Scientific Officer 02/03/2021 27,150
Roberts Christopher D. Chief Scientific Officer 02/03/2021 63,375
Hatzis-Schoch Brent See Remarks 01/12/2021 94,500
Hatzis-Schoch Brent See Remarks 01/12/2021 394,041
Leggett Thomas Chief Financial Officer 01/08/2021 32,580
Leggett Thomas Chief Financial Officer 01/08/2021 101,820
Roberts Christopher D. Chief Scientific Officer 01/04/2021 27,150
Roberts Christopher D. Chief Scientific Officer 01/04/2021 78,525
Epstein David M. See Remarks 01/04/2021 19,260
Epstein David M. See Remarks 01/04/2021 373,505
Hatzis-Schoch Brent See Remarks 12/28/2020 17,280
INGRAM ROBERT ALEXANDER Director 12/15/2020 17,316
Roberts Christopher D. Chief Scientific Officer 12/15/2020 34,752
Hatzis-Schoch Brent See Remarks 12/14/2020 13,050
Hatzis-Schoch Brent See Remarks 12/14/2020 142,522
Epstein David M. See Remarks 12/15/2020 16,050
Leggett Thomas Chief Financial Officer 12/08/2020 32,580
Leggett Thomas Chief Financial Officer 12/08/2020 101,327
Roberts Christopher D. Chief Scientific Officer 12/03/2020 27,150
Roberts Christopher D. Chief Scientific Officer 12/03/2020 81,055
Epstein David M. See Remarks 12/01/2020 19,260
Epstein David M. See Remarks 12/01/2020 392,574
Bolzon Bradley J PhD Director 11/30/2020 344,513
Versant Venture Capital VI, L.P. 10% Owner 11/30/2020 344,513
Versant Venture Capital VI, L.P. 10% Owner 11/19/2020 3,791,330
Versant Venture Capital VI, L.P. 10% Owner 11/19/2020 500,531
Bolzon Bradley J PhD Director 11/19/2020 4,291,861
Bolzon Bradley J PhD Director 11/17/2020 138,611
Bolzon Bradley J PhD Director 11/18/2020 17,738
Versant Venture Capital VI, L.P. 10% Owner 11/18/2020 15,653
Versant Venture Capital VI, L.P. 10% Owner 11/18/2020 2,085
Versant Venture Capital VI, L.P. 10% Owner 11/17/2020 122,450
Versant Venture Capital VI, L.P. 10% Owner 11/17/2020 16,161
Versant Venture Capital VI, L.P. 10% Owner 11/16/2020 5,843
Versant Venture Capital VI, L.P. 10% Owner 11/16/2020 759
Versant Venture Capital VI, L.P. 10% Owner 11/13/2020 134,253
Versant Venture Capital VI, L.P. 10% Owner 11/13/2020 17,731
Bolzon Bradley J PhD Director 11/16/2020 6,603
Bolzon Bradley J PhD Director 11/13/2020 151,984
Versant Venture Capital VI, L.P. 10% Owner 11/12/2020 470,526
Versant Venture Capital VI, L.P. 10% Owner 11/12/2020 62,116
Bolzon Bradley J PhD Director 11/12/2020 532,642
Roberts Christopher D. Chief Scientific Officer 11/11/2020 54,300
Roberts Christopher D. Chief Scientific Officer 11/11/2020 174,500
Hatzis-Schoch Brent See Remarks 11/12/2020 13,050
Hatzis-Schoch Brent See Remarks 11/12/2020 138,607
Versant Venture Capital VI, L.P. 10% Owner 11/11/2020 51,091
Versant Venture Capital VI, L.P. 10% Owner 11/10/2020 805,755
Versant Venture Capital VI, L.P. 10% Owner 11/10/2020 106,381
Versant Venture Capital VI, L.P. 10% Owner 11/11/2020 387,127
Bolzon Bradley J PhD Director 11/11/2020 438,217
Bolzon Bradley J PhD Director 11/10/2020 912,136
Leggett Thomas Chief Financial Officer 11/09/2020 32,580
Leggett Thomas Chief Financial Officer 11/09/2020 98,892
Versant Venture Capital VI, L.P. 10% Owner 11/09/2020 183,954
Versant Venture Capital VI, L.P. 10% Owner 11/09/2020 24,296
Versant Venture Capital VI, L.P. 10% Owner 11/06/2020 90,706
Versant Venture Capital VI, L.P. 10% Owner 11/06/2020 11,993
Bolzon Bradley J PhD Director 11/06/2020 102,698
Bolzon Bradley J PhD Director 11/09/2020 208,250
Bolzon Bradley J PhD Director 11/05/2020 293,287
Bolzon Bradley J PhD Director 11/04/2020 82,839
Versant Venture Capital VI, L.P. 10% Owner 11/04/2020 9,676
Versant Venture Capital VI, L.P. 10% Owner 11/05/2020 259,079
Versant Venture Capital VI, L.P. 10% Owner 11/05/2020 34,208
Versant Venture Capital VI, L.P. 10% Owner 11/04/2020 73,164
Roberts Christopher D. Chief Scientific Officer 11/03/2020 27,150
Roberts Christopher D. Chief Scientific Officer 11/03/2020 79,873
Epstein David M. See Remarks 11/02/2020 19,260
Epstein David M. See Remarks 11/02/2020 373,656
Versant Venture Capital VI, L.P. 10% Owner 10/27/2020 3,072
Versant Venture Capital VI, L.P. 10% Owner 10/26/2020 238,394
Versant Venture Capital VI, L.P. 10% Owner 10/26/2020 31,473
Versant Venture Capital VI, L.P. 10% Owner 10/27/2020 23,354
Bolzon Bradley J PhD Director 10/27/2020 26,426
Bolzon Bradley J PhD Director 10/26/2020 269,867
Versant Venture Capital VI, L.P. 10% Owner 10/15/2020 10,802
Versant Venture Capital VI, L.P. 10% Owner 10/19/2020 124,998
Versant Venture Capital VI, L.P. 10% Owner 10/19/2020 16,515
Versant Venture Capital VI, L.P. 10% Owner 10/16/2020 258,410
Versant Venture Capital VI, L.P. 10% Owner 10/16/2020 34,110
Versant Venture Capital VI, L.P. 10% Owner 10/15/2020 81,694
Bolzon Bradley J PhD Director 10/19/2020 141,513
Bolzon Bradley J PhD Director 10/16/2020 292,520
Bolzon Bradley J PhD Director 10/15/2020 92,496
Bolzon Bradley J PhD Director 10/14/2020 182,031
Bolzon Bradley J PhD Director 10/13/2020 391,984
Versant Venture Capital VI, L.P. 10% Owner 10/14/2020 160,787
Versant Venture Capital VI, L.P. 10% Owner 10/14/2020 21,244
Versant Venture Capital VI, L.P. 10% Owner 10/13/2020 346,271
Versant Venture Capital VI, L.P. 10% Owner 10/13/2020 45,713
Hatzis-Schoch Brent See Remarks 10/12/2020 13,050
Hatzis-Schoch Brent See Remarks 10/12/2020 133,331
Bolzon Bradley J PhD Director 10/12/2020 13,243
Bolzon Bradley J PhD Director 10/09/2020 127,933
Bolzon Bradley J PhD Director 10/08/2020 616,748
Versant Venture Capital VI, L.P. 10% Owner 10/12/2020 1,556
Versant Venture Capital VI, L.P. 10% Owner 10/09/2020 113,018
Versant Venture Capital VI, L.P. 10% Owner 10/09/2020 14,914
Versant Venture Capital VI, L.P. 10% Owner 10/08/2020 544,814
Versant Venture Capital VI, L.P. 10% Owner 10/08/2020 71,934
Versant Venture Capital VI, L.P. 10% Owner 10/12/2020 11,687
Leggett Thomas Chief Financial Officer 10/08/2020 32,580
Leggett Thomas Chief Financial Officer 10/08/2020 100,576
Bolzon Bradley J PhD Director 10/07/2020 934,079
Bolzon Bradley J PhD Director 10/06/2020 601,653
Versant Venture Capital VI, L.P. 10% Owner 10/06/2020 531,477
Versant Venture Capital VI, L.P. 10% Owner 10/06/2020 70,176
Versant Venture Capital VI, L.P. 10% Owner 10/07/2020 825,154
Versant Venture Capital VI, L.P. 10% Owner 10/07/2020 108,924
Roberts Christopher D. Chief Scientific Officer 10/05/2020 27,150
Roberts Christopher D. Chief Scientific Officer 10/05/2020 78,188
Epstein David M. See Remarks 10/01/2020 19,260
Epstein David M. See Remarks 10/01/2020 363,962
INGRAM ROBERT ALEXANDER Director 09/30/2020 152,285
Hatzis-Schoch Brent See Remarks 09/14/2020 13,050
Hatzis-Schoch Brent See Remarks 09/14/2020 126,583
Leggett Thomas Chief Financial Officer 09/14/2020 32,580
Leggett Thomas Chief Financial Officer 09/14/2020 93,000
Roberts Christopher D. Chief Scientific Officer 09/03/2020 27,150
Roberts Christopher D. Chief Scientific Officer 09/03/2020 73,987
Versant Venture Capital VI, L.P. 10% Owner 08/10/2020 23,953
Versant Venture Capital VI, L.P. 10% Owner 08/11/2020 221,380
Versant Venture Capital VI, L.P. 10% Owner 08/11/2020 29,211
Versant Venture Capital VI, L.P. 10% Owner 08/10/2020 181,446
Bolzon Bradley J PhD Director 08/11/2020 250,591
Bolzon Bradley J PhD Director 08/10/2020 205,398
Versant Venture Capital VI, L.P. 10% Owner 02/03/2020 7,525,558
Versant Venture Capital VI, L.P. 10% Owner 02/03/2020 9,474,426
Bolzon Bradley J PhD Director 02/03/2020 16,999,984
Shah Rajeev M. Director 02/03/2020 19,000,000
Hatzis-Schoch Brent See Remarks 02/03/2020 57,000
Behbahani Ali Director 02/03/2020 15,200,000
Flynn James E 10% Owner 02/03/2020 7,600,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
12/31/2021
0.23%
1Q
03/31/2022
09/30/2021
0.27%
2Q
03/31/2022
06/30/2021
0.33%
3Q
03/31/2022
03/31/2021
0.41%
4Q
03/31/2022
12/31/2020
10.22%
5Q
03/31/2022
09/30/2020
13.84%
6Q
03/31/2022
06/30/2020
21.70%
7Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2021
0.23%
1Q
09/30/2021
0.27%
2Q
06/30/2021
0.33%
3Q
03/31/2021
0.41%
4Q
12/31/2020
10.22%
5Q
09/30/2020
13.84%
6Q
06/30/2020
21.70%
7Q
Load More